COMP <GO>
INGN vs ZJYL // ALTMAN Z-SCORE & DEBT/EQUITY
Inogen Inc (NASDAQ) VS. JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) • 15-METRIC TALLY: INGN 4
— ZJYL 3
■ METRIC PARITY
LAST: $7.26 (+0.14%) • MKT CAP: $192.7M
balance-sheet
1.46
LAST: $1.86 (-2.10%) • MKT CAP: $294.2M
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INGN VS. ZJYL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INGN | ZJYL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 52.20% | 29.20% | +23.00 | INGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 47.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.13% | -1.27% | -5.86 | ZJYL | /fcf-yield <GO> |
| Operating Margin | -10.20% | 2.90% | -13.10 | ZJYL | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 5.80% | +1.90 | INGN | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | -12.00% | +17.90 | INGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.46 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.6 | 44.3 | +24.30 | INGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $192.7M | $294.2M | -$101.6M | ZJYL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INGN REV | ZJYL REV | INGN GROSS % | ZJYL GROSS % | INGN FCF | ZJYL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $295.3M | $20.7M | 52.2% | 29.2% | -$13.7M | -$3.7M |
| FY 2024 | $278.8M | $23.5M | 55.5% | 40.4% | $2.6M | -$1.4M |
| FY 2023 | $251.6M | $19.8M | — | — | -$3.2M | $3.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INGN // BETA —
ZJYL // BETA —